Indicators

Latest News about CYBN

Recent news which mentions CYBN

< Previous 1 2 3 4 5 6 7 8 9

...

MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday

February 13, 2025

Is Your Mind Ready to Consider Investing in Psychedelics Stocks?

November 29, 2024

Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression

November 13, 2024

EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program

October 24, 2024

Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More

September 06, 2024

CYBN Stock Earnings: Cybin Beats EPS for Q1 2024

August 09, 2024

EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves

July 31, 2024

3 Biotech Stocks That Could Make Your Summer Unforgettable

July 30, 2024

Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns

July 03, 2024

3 Psychedelic Stocks to Buy on the Dip: Summer 2024

July 02, 2024

CYBN Stock Earnings: Cybin Beats EPS for Q4 2023

June 26, 2024

Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development

June 26, 2024

Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More

June 18, 2024

Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment

June 05, 2024

Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon

May 09, 2024

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More

March 30, 2024

3 Penny Stocks That Could Be Multibaggers in the Making: March Edition

March 26, 2024

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More

March 20, 2024

FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement

March 13, 2024

3 High-Potential Penny Stocks to Turn $1000 into $1 million

March 10, 2024

Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More

March 04, 2024

Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss

February 16, 2024

Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More

February 15, 2024

Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More

January 27, 2024

FDA Green Lights Cybin's Psychedelic Clinical Study Assessing Generalized Anxiety

January 23, 2024

Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More

January 15, 2024

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More

January 12, 2024

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond

January 10, 2024

Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results

January 09, 2024

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

January 06, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.